Amatsigroup is the French leader of drug development services to the pharmaceutical industry (laboratories and biotechs). The Group originate in 2011 from the merger of two industry players triggered by Ekkio Capital. The company experienced a strong growth (organic and acquisitions), driven by the increase of the outsourcing ratio.
Investment date: 2010
Exit date: 2017
Investment type: OBO
